S. L. Keely

发表

Activation of cAMP-dependent protein kinase without a corresponding increase in phosphorylase activity.

S. L. Keely, 1977, Research communications in chemical pathology and pharmacology.

Regulation of cardiac cyclic GMP-dependent protein kinase.

T. Lincoln, S. L. Keely, 1981, Biochimica et biophysica acta.

Effects of anagrelide on platelet cAMP levels, cAMP-dependent protein kinase and thrombin-induced Ca++ fluxes.

R. Grove, S. Seiler, H. C. Stanton, 1987, The Journal of pharmacology and experimental therapeutics.

Hormonal regulation of adenosine 3',5'-monophosphate-dependent protein kinase.

T. Soderling, J. Corbin, C. Park, 1975, Advances in cyclic nucleotide research.

On the question of cyclic GMP as the mediator of the effects of acetylcholine on the heart.

T. Lincoln, S. L. Keely, 1978, Biochimica et biophysica acta.

Prostaglandin E1 activation of heart cAMP-dependent protein kinase: apparent dissociation of protein kinase activation from increases in phosphorylase activity and contractile force.

S. L. Keely, 1979, Molecular pharmacology.

Alpha adrenergic involvement in heart metabolism: effects on adenosine cyclic 3',5'-monophosphate, adenosine cyclic 3',5'-monophosphate-dependent protein kinase, guanosine cyclic 3',5'-monophosphate, and glucose transport.

T. Lincoln, J. Corbin, S. L. Keely, 1977, Molecular pharmacology.

Involvement of cAMP-dependent protein kinase in the regulation of heart contractile force.

J. Corbin, S. L. Keely, 1977, The American journal of physiology.

The 3-arylpyrrolidine alkaloid synthon

S. L. Keely, F. C. Tahk, A. J. Martinez, 1970 .

A synthetic route to 1,2,4,5-tetrahydro-3H-benz[e]indoles

S. L. Keely, F. C. Tahk, A. J. Martinez, 1969 .

The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues.

J. Corbin, C. Park, C. R. Park, 1975, The Journal of biological chemistry.

Compartmentalization of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in heart tissue.

T. Lincoln, P. Sugden, J. Corbin, 1977, The Journal of biological chemistry.

Chapter 27. Alkaloids and Other Natural Products

R. W. Doskotch, S. L. Keely, 1971 .

Regulation of adenosine 3:5-monophosphate-dependent protein kinase.

T. Soderling, J. Corbin, C. Park, 1975, The Journal of biological chemistry.

Control of Metabolic Processes by cAMP-Dependent Protein Phosphorylation

T. Soderling, P. Sugden, J. Corbin, 1976 .

On the question of translocation of heart cAMP-dependent protein kinase.

J. Corbin, C. Park, C. R. Park, 1975, Proceedings of the National Academy of Sciences of the United States of America.

New sesquiterpene lactones from Liriodendron tulipifera

R. W. Doskotch, C. D. Hufford, F. El-Feraly, 1975 .

Characterization and regulation of heart adenosine 3':5'-monophosphate-dependent protein kinase isozymes.

J. Corbin, S. L. Keely, 1977, The Journal of biological chemistry.

Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844).

J. Buchanan, J. Fleming, S. Seiler, 1989, Thrombosis research.

Interaction of acetylcholine and epinephrine on heart cyclic AMP-dependent protein kinase.

T. Lincoln, J. Corbin, S. L. Keely, 1978, The American journal of physiology.

Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.

N. Meanwell, S. Seiler, A. Arnold, 1990, The Journal of pharmacology and experimental therapeutics.